Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery

Condition:   Childhood CraniopharyngiomaInterventions:   Biological: peginterferon alfa-2b;   Other: laboratory biomarker analysisSponsors:   Pediatric Brain Tumor Consortium;   Pediatric Brain Tumor Consortium;   National Cancer Institute (NCI)Not yet recruiting - verified October 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials